chartexchange

LGND
Ligand Pharmaceuticals Inc.
stockNASDAQ

At CloseNov 13, 2026 3:59:59 PM EST
309.05USD-2.283%(-7.22)135,792
Pre-marketNov 13, 2026 9:28:30 AM EST
316.50USD+0.073%(+0.23)
After-hoursNov 13, 2026 4:03:30 PM EST
308.60USD-0.146%(-0.45)
Loading…
Loading…
Healthcare
Biotechnology
CEO
John Higgins
HQ
San Diego, CA, USA
Previous Close
$316.27
Beta
0.89
52-Week High
$326.63 2026-07-08
52-Week Low
$175.89 2026-01-13
SMA 50
$301.33
SMA 200
$257.80
Avg. Vol 10D
205,387
Avg. Vol 30D
219,647
Avg. Vol 90D
251,113
Relative Vol
0.62
19.55M
0.2800%
Apr 3, 2007 · $2.500
Nov 19, 2010 · 1-for-5.9999 (reverse)
LGND Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGND Performance
PeriodPriceDateChangeBeta
1W306.202026-11-06+0.96%0.907
1M303.532026-10-13+1.85%1.212
3M288.822026-08-13+7.04%1.047
6M221.212026-05-13+39.75%0.746
1Y201.272025-11-13+53.59%0.885
2Y122.082024-11-13+153.23%—
5Y161.412021-11-12+91.53%1.108
LGND Stock Summary

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $309.14, and today's volume is 135,792. LGND is down 2.254% today. The 30 day average volume is 219,647. LGND market cap is $6.18B with 20.00M shares outstanding.